Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and.

Slides:

Advertisements

Similar presentations

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.

Advertisements

Enrollment, Randomization, and Follow-up of Study Participants ADVANCE Collaborative Group. N Engl J Med 2008;358:

Statistics: Unlocking the Power of Data Lock 5 Section 6.8 Confidence Interval for a Difference in Proportions.

Health April 13, 2017.

Copyright © 2015 American Medical Association. All rights reserved.

Copyright © 2005 American Medical Association. All rights reserved.

Hypertension treatment guidelines from the United Kingdom’s National Institute for Health and Care Excellence. Guidelines identify angiotensin-converting.

Copyright © 2002 American Medical Association. All rights reserved.

Copyright © 2014 American Medical Association. All rights reserved.

Mean scores for symptoms of mental illness between 1994/95 and 2004/05 in participants aged 10–11 years (A), between 1996/97 and 2007/08 in those aged.

Copyright © 2004 American Medical Association. All rights reserved.

Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.

Progress and Promise in RAAS Blockade

Viper venom for diabetic nephropathy

Frederic Rahbari-Oskoui, MD, MS American Journal of Kidney Diseases

Volume 89, Issue 6, Pages (June 2016)

Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.

Rajiv Agarwal, John W. Kusek, Maria K. Pappas Kidney International

Outcome Relative risk with beta blockers 95% CI Stroke –1.30

Viper venom for diabetic nephropathy

Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74

Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization

Propofol as a panacea for acute kidney injury?

Volume 81, Issue 7, Pages (April 2012)

Fig. 2. Evidence-based medication prescriptions

Nat. Rev. Cardiol. doi: /nrcardio

Volume 80, Issue 9, Pages (November 2011)

Database-specific risk of ventricular arrhythmia associated with current use of azithromycin compared with current use of amoxicillin (2-stage random-effects.

Effects on pain and disability of anticonvulsants for low back pain with or without radiating leg pain or lumbar radicular pain. Effects on pain and disability.

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.

Yousef Rezaei, MD American Journal of Kidney Diseases

Volume 72, Issue 12, Pages (December 2007)

Berger JS, et al. JAMA 2009;301:

Flow diagram for exclusions of trials identified RCT indicates randomized controlled trial Hulten E, et al. Arch Intern Med 2006;166:

Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies (2,9) Green diamonds indicate Class I guideline recommendations, while.

Decline in the risk of carotid occlusion with more intensive medical therapy. Decline in the risk of carotid occlusion with more intensive medical therapy.

Rami Doukky et al. JCHF 2016;4:24-35

Statin Use and Risk of COPD Exacerbation Requiring Hospitalization

Managing Blood Pressure

Adjunctive Therapies in the Treatment of Acute Coronary Syndromes

Relative Risk of Onset of Cancer from the Cholesterol Treatment Trialists’ (CTT) Meta-Analysis of Statin Trials, According to Year of Onset Risk ratios.

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target American.

Carmine Zoccali, Francesca Mallamaci Kidney International

Svend A. Mortensen et al. JCHF 2014;2:

Standard mean difference of change in creatinine between the intravenous (IV) versus oral (PO) arm. Standard mean difference of change in creatinine between.

Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization

Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end.

Volume 81, Issue 11, Pages (June 2012)

(A) Distribution of CsA nephrotoxicity lesions according to antihypertensive treatment and CsA C2 levels. (A) Distribution of CsA nephrotoxicity lesions.

Unadjusted odds ratio of death at 6 mo for medications (β blockers [BBL], angiotensin-converting enzyme inhibitors [ACEI]/angiotensin receptor blockers.

Increase of physical activity over time associated with lower HF risk

Risk of venous thromboembolism by ABO blood type, factor V Leiden R506Q and prothrombin G20210A mutations among individuals in the Copenhagen General.

Meta-analysis of five prospective studies examining the associations between urinary melatonin secretion and breast cancer risk. Meta-analysis of five.

An updated general approach for achieving BP goals in people with diabetes. An updated general approach for achieving BP goals in people with diabetes.

Schematic of the interaction between the renin-angiotensin-aldosterone system (RAAS) system and the natriuretic peptides and how the RAAS modulators and.

Percentage of patients found with a kidney function too low for recommended use of the drug using estimated glomerular filtration rate compared with creatinine.

Pooled estimate of relative risk and 95% CIs of colorectal cancer associated with metformin therapy based on four studies comprising 107,961 diabetic patients.

Effect of methylprednisolone versus placebo on the risk of acute kidney injury: subgroup analysis by preoperative chronic kidney disease. Effect of methylprednisolone.

Effectiveness of vaccination for influenza in the current and any of the 3 previous seasons in preventing nonsevere and severe cases of influenza by season,

Kernel density plots of propensity score distributions in the included and excluded populations. Kernel density plots of propensity score distributions.

Fig. 3: Possible algorithm for controlling blood pressure in diabetic patients with microalbuminuria. [This algorithm is based on the opinions and practice.

Risk of 30-day hospital encounter with ventricular arrhythmia

Cases of and deaths from prostate cancer, with associated age-standardized incidence and mortality (per men), among Canadian men aged 45 years.

Fig. 1: Relative risks of death from any cause among participants with various risk factors (e.g., history of hypertension, chronic obstructive pulmonary.

Kaplan-Meier curve of the primary outcome in patients prescribed ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB). Kaplan-Meier curve of the.

Effectiveness of vaccination for influenza in the current and 3 previous seasons in preventing nonsevere and severe cases of influenza. Effectiveness of.

Relative risk by median risk exposure for 40-year-old men.

Presentation transcript:

Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and risk of cancer. Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and risk of cancer. A relative risk greater than 1.0 indicates an increased risk for cancer. *Yang and coauthors35 reported estimates separately for two groups totalling 205 cases of cancer: those with a leukocyte count of 5.8 × 109/L or greater, and those with a lower leukocyte count. †Total number of cancer cases was higher than the number reported among people using ACE inhibitors or angiotensin-receptor blockers. ‡Total number of cancer cases was higher than the number reported among people not using ACE inhibitors or angiotensin-receptor blockers. CI = confidence interval, NA = not available. Chan Yoon et al. CMAJ 2011;183:E1073-E1084 ©2011 by Canadian Medical Association